Impact of a Digital Self-Management Program on A1C for Individuals With Type 2 Diabetes
Enhancing Cardiometabolic Care Study
Sponsor: Omada Health, Inc.
Terminated
Study terminated prematurely due to operational futility.
Other Type 2 Diabetes trials with similar outcome
A NA clinical study on Type 2 Diabetes, this trial is terminated or withdrawn. The trial is conducted by Omada Health, Inc. and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jun 2022 — Jul 2024 [monthly]
Terminated NA
Status: Enrolling By Invitation → Terminated
-
Jun 2021 — Jun 2022 [monthly]
Enrolling By Invitation NA
First recorded
Mar 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Omada Health, Inc.
- Palo Alto Medical Foundation
- Sutter Health
For direct contact, visit the study record on ClinicalTrials.gov .